Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
204 Leser
Artikel bewerten:
(1)

vVARDIS Advances Sustainable, Drill-Free Caries Management Consistent With WHO's Forward-Looking Vision for Environmentally Friendly Oral Health

ZUG, SWITZERLAND / ACCESS Newswire / January 22, 2026 / vVARDIS, a Swiss high-growth healthcare company welcomes the release of the World Health Organisation's (WHO) Guideline on Environmentally Friendly and Less Invasive Oral Health Care for Preventing and Managing Dental Caries, a global crisis affecting an estimated 2.5 billion people worldwide, according to the WHO. This guideline supports the Bangkok Declaration and the transition to preventive, less invasive, climate resilient, environmentally sustainable, and safe oral healthcare. This perspective aligns with a broader shift toward a salutogenic model of sustainable oral health, one that prioritizes the preservation and regeneration of natural dental tissues.

This forward-looking perspective is echoed in the article "Equity and integration; why the oral healthcare community urgently needs to reflect on its approach to caries management just published in the International Journal of Equity in Health, which introduces a biomimetic formulation, in a product known as CurodontTM Repair, as an example of a non-invasive and environmentally-friendly solution for treatment of non-cavitated caries. CurodontTM Repair, which has been developed with a proprietary process to assure effective application to the early caries lesion, promotes a biomimetic repair process that helps to arrest the progression of early caries and facilitates mineral crystal generation throughout the depth of the lesion, restoring the enamel structure from within, offering a non-invasive, mercury-free approach to caries management consistent with WHO's forward-looking vision. Developed over 25 years of research, vVARDIS biomimetic science has been perfected and clinically validated through randomized controlled trials, long-term real-world evidence, as well as meta-analyses, demonstrating its safety and more than 90% clinical efficacy in arresting and reversing early carious lesions.

By minimizing the need for drilling, this approach can contribute to lower waste generation, reducing energy consumption, and promoting more efficient use of resources over a patient's lifetime.

A salutogenic model of sustainable oral health that integrates biomimetic science into the Minimum Intervention Oral Care (MIOC) framework can help advance the six guiding principles of the WHO Global Oral Health Action Plan and for dentists combines clinical effectiveness with ecological awareness, caries management with overall health and well-being.

About vVARDIS AG

vVARDIS is a Swiss high-growth healthcare company located in Zug, Switzerland that offers groundbreaking biomimetic, non-invasive solutions for dental professionals under the Curodont brand. Founded by Drs. Haley and Goly Abivardi, sisters, Swiss dentists, innovators, and awarded entrepreneurs, vVARDIS is the result of more than 25 years of research, paired with the commitment of its founders to make an impact on people's lives, especially the underserved. Curodont is already mentioned in lectures at renowned universities as a standard of care for the treatment of early decay. vVARDIS is a member of the World Economic Forum's Innovator Communities.

For more information on vVARDIS products, including Curodont Repair Fluoride Plus available in the U.S., visit www.vVARDIS.com.

References

UNEP/MC/COP.6/INF/31/Add.1 - World Health Organization guideline on environmentally friendly and less invasive oral health care for preventing and managing dental caries. https://minamataconvention.org/sites/default/files/documents/information_document/UNEP-MC-COP6-INF31-Add1-WHO-Dental-Amalgam_English.pdf.

Fisher J et al. Int J Equity Health 2026
Alkilzy M et al. J Dent Res 2018
Bröseler F et al. Clin Oral Investig 2020
Welk A et al. Sci Rep 2020
Godenzi D et al. J Am Dent Assoc 2023
Keeper J et al. J Am Dent Assoc 2023

SOURCE: vVardis AG



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/vvardis-advances-sustainable-drill-free-caries-management-consistent-1129956

© 2026 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.